Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016 (2016), Article ID 1627184, 9 pages
http://dx.doi.org/10.1155/2016/1627184
Research Article

A Novel Murine Model of Parvovirus Associated Dilated Cardiomyopathy Induced by Immunization with VP1-Unique Region of Parvovirus B19

1Department of Integrative Pathophysiology, Medical Faculty Mannheim, Mannheim, Germany
2Department of Pathology, Forensic Medicine and Pharmacology, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
3Department of Biological Models, Institute of Biochemistry, Vilnius University, Vilnius, Lithuania
4State Research Institute, Centre for Innovative Medicine, Department of Stem Cell Biology, Vilnius, Lithuania
5Medical Faculty Mannheim, Institute of Pathology, Mannheim, Germany
6Medical Faculty Mannheim, Medical Research Centre, Mannheim, Germany

Received 17 May 2016; Revised 9 August 2016; Accepted 14 September 2016

Academic Editor: Andrea Vecchione

Copyright © 2016 Julijus Bogomolovas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Kawai, “From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future,” Circulation, vol. 99, no. 8, pp. 1091–1100, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Pankuweit and K. Klingel, “Viral myocarditis: from experimental models to molecular diagnosis in patients,” Heart Failure Reviews, vol. 18, no. 6, pp. 683–702, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. E. D. Heegaard and K. E. Brown, “Human parvovirus B19,” Clinical Microbiology Reviews, vol. 15, no. 3, pp. 485–505, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Zuffi, E. Manaresi, G. Gallinella et al., “Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans,” Viral Immunology, vol. 14, no. 2, pp. 151–158, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Saikawa, S. Anderson, M. Momoeda, S. Kajigaya, and N. S. Young, “Neutralizing linear epitopes of b19 parvovirus cluster in the vP1 unique and vP1-vP2 junction regions,” Journal of Virology, vol. 67, no. 6, pp. 3004–3009, 1993. View at Google Scholar
  6. C. Filippone, N. Zhi, S. Wong et al., “VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones,” Virology, vol. 374, no. 2, pp. 444–452, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Leisi, N. Ruprecht, C. Kempf, and C. Ros, “Parvovirus B19 uptake is a highly selective process controlled by VP1u, a novel determinant of viral tropism,” Journal of Virology, vol. 87, no. 24, pp. 13161–13167, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Nie, G. Zhang, D. Xu et al., “The VP1-unique region of parvovirus B19 induces myocardial injury in mice,” Scandinavian Journal of Infectious Diseases, vol. 42, no. 2, pp. 121–128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. B.-S. Tzang, T.-M. Lin, C.-C. Tsai, J.-D. Hsu, L.-C. Yang, and T.-C. Hsu, “Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein,” Molecular Immunology, vol. 48, no. 12-13, pp. 1518–1524, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Čiháková, R. B. Sharma, D. Fairweather, M. Afanasyeva, and N. R. Rose, “Animal models for autoimmune myocarditis and autoimmune thyroiditis,” in Autoimmunity, vol. 102 of Methods in Molecular Medicine, pp. 175–193, Humana Press, Totowa, NJ, USA, 2004. View at Publisher · View at Google Scholar
  11. J. Bogomolovas, B. Simon, M. Sattler, and G. Stier, “Screening of fusion partners for high yield expression and purification of bioactive viscotoxins,” Protein Expression and Purification, vol. 64, no. 1, pp. 16–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. L. E. Teichholz, T. Kreulen, M. V. Herman, and R. Gorlin, “Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy,” The American Journal of Cardiology, vol. 37, no. 1, pp. 7–11, 1976. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Schindelin, I. Arganda-Carreras, E. Frise et al., “Fiji: an open-source platform for biological-image analysis,” Nature Methods, vol. 9, no. 7, pp. 676–682, 2012. View at Google Scholar
  14. A. Subramanian, H. Kuehn, J. Gould, P. Tamayo, and J. P. Mesirov, “GSEA-P: a desktop application for gene set enrichment analysis,” Bioinformatics, vol. 23, no. 23, pp. 3251–3253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Kanehisa and S. Goto, “KEGG: kyoto encyclopedia of genes and genomes,” Nucleic Acids Research, vol. 28, no. 1, pp. 27–30, 2000. View at Publisher · View at Google Scholar
  16. D. Merico, R. Isserlin, O. Stueker, A. Emili, and G. D. Bader, “Enrichment map: a network-based method for gene-set enrichment visualization and interpretation,” PLoS ONE, vol. 5, no. 11, Article ID e13984, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Afanasyeva, D. Georgakopoulos, D. F. Belardi et al., “Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function,” The American Journal of Pathology, vol. 164, no. 3, pp. 807–815, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Afanasyeva, D. Georgakopoulos, and N. R. Rose, “Autoimmune myocarditis: cellular mediators of cardiac dysfunction,” Autoimmunity Reviews, vol. 3, no. 7-8, pp. 476–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. C. V. Thomas, M. L. Coker, J. L. Zellner, J. R. Handy, A. J. Crumbley III, and F. G. Spinale, “Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy,” Circulation, vol. 97, no. 17, pp. 1708–1715, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. C. M. Tummalapalli, B. J. Heath, and S. C. Tyagi, “Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts,” Journal of Cellular Biochemistry, vol. 80, no. 4, pp. 512–521, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. A. D'Ambrosio, G. Patti, A. Manzoli et al., “The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review,” Heart, vol. 85, no. 5, pp. 499–504, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. H. Mahrholdt, A. Wagner, C. C. Deluigi et al., “Presentation, patterns of myocardial damage, and clinical course of viral myocarditis,” Circulation, vol. 114, no. 15, pp. 1581–1590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. B. D. Bültmann, K. Klingel, K. Sotlar et al., “Fatal parvovirus b19–associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell–mediated disease,” Human Pathology, vol. 34, no. 1, pp. 92–95, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. B.-S. Tzang, C.-C. Tsai, C.-C. Chiu, J.-Y. Shi, and T.-C. Hsu, “Up-regulation of adhesion molecule expression and induction of TNF-α on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein,” Clinica Chimica Acta, vol. 395, no. 1-2, pp. 77–83, 2008. View at Publisher · View at Google Scholar · View at Scopus